Mr David Tamblyn
AHTA Manager
School of Public Health
Faculty of Health and Medical Sciences
Mr David Tamblyn is the Manager at Adelaide Health Technology Assessment (AHTA) in the School of Public Health, University of Adelaide. He has worked in the field of health technology assessment for over 10 years, and has experience evaluating pharmaceuticals, devices and medical services. He has been involved in HTA evaluations for both reimbursement and regulatory purposes, and in the development of national guidelines to inform the assessment of pharmaceuticals and medical services.
Mr Tamblyn's qualifications include a Masters of Public Health, University of Adelaide and Bachelor of Health Sciences, University of Adelaide. Mr Tamblyn is a Deputy Editor for the International Journal of Technology Assessment in Health Care (IJTAHC), a committee member of the TGA Expert Advisory Panel on Breast Implant Associated Anaplastic Large Cell Lymphoma, a committee member of the South Australian Policy Advisory Committee for Technology (SAPACT), and a committee member of the South Australian Medicines Evaluation Panel (SAMEP).
-
Appointments
Date Position Institution name 2022 - ongoing Lecturer University of Adelaide -
Education
Date Institution name Country Title University of Adelaide Australia Bachelor University of Adelaide Australia Masters -
Research Interests
-
Journals
-
Books
Year Citation 2024 Merlin, T., Laka, M., Carter, D., Gao, Y., Choi, Y. -S., Parsons, J., . . . Tamblyn, D. (2024). Health Technology Assessment Policy and Methods Review: HTA Pathways and Processes, Clinical Evaluation Methods and Horizon Scanning. Canberra, ACT: Commonwealth of Australia. 2011 Doidge, J., Merlin, T., Liufu, Z., Tamblyn, D., Jia, L., & Hiller, J. (2011). Review of Interim Funded Service: Vertebroplasty and New Review of Kyphoplasty. Australia: Commonwealth of Australia. 2011 Tamblyn, D., Ellery, B., & Merlin, T. (2011). Review of Interim Funded Service: Brachytherapy for the Treatment of Prostate Cancer: assessment report. Australia: Commonwealth of Australia. -
Book Chapters
Year Citation 2024 Laka, M., Carter, D., Gao, Y., Choi, Y. -S., Tamblyn, D., & Merlin, T. (2024). International health technology market approval, funding and assessment pathways.. In T. Merlin, & D. Tamblyn (Eds.), Health Technology Assessment Policy and Methods Review: HTA Pathways and Processes, Clinical Evaluation Methods and Horizon Scanning (pp. 34-163). Canberra, ACT: Commonwealth of Australia. 2024 Laka, M., Carter, D., Gao, Y., Choi, Y. -S., Tamblyn, D., & Merlin, T. (2024). International health technology market approval, funding and assessment pathways.. In T. Merlin, & D. Tamblyn (Eds.), Health Technology Assessment Policy and Methods Review: HTA Pathways and Processes, Clinical Evaluation Methods and Horizon Scanning (pp. 34-163). Canberra, ACT: Commonwealth of Australia. 2024 Parsons, J., Milverton, J., Ellery, B., Tamblyn, D., & Merlin, T. (2024). Horizon scanning and early assessment.. In T. Merlin, & D. Tamblyn (Eds.), Health Technology Assessment Policy and Methods Review: HTA Pathways and Processes, Clinical Evaluation Methods and Horizon Scanning (pp. 164-245). Canberra, ACT: Commonwealth of Australia. 2024 Parsons, J., Milverton, J., Ellery, B., Tamblyn, D., & Merlin, T. (2024). Horizon scanning and early assessment.. In T. Merlin, & D. Tamblyn (Eds.), Health Technology Assessment Policy and Methods Review: HTA Pathways and Processes, Clinical Evaluation Methods and Horizon Scanning (pp. 164-245). Canberra, ACT: Commonwealth of Australia. 2024 Newton, S., Hill, H., & Merlin, T. (2024). HTA Methods: Determination of Population, Intervention, Comparator, and Outcome (PICO). In T. Merlin, & D. Tamblyn (Eds.), Health Technology Assessment Policy and Methods Review: HTA Pathways and Processes, Clinical Evaluation Methods and Horizon Scanning (pp. 246-346). Canberra, ACT: Commonwealth of Australia. 2024 Tamblyn, D., Morona, J., Carter, D., Kessels, S., & Merlin, T. (2024). Clinical Evaluation Methods in HTA. In T. Merlin, & D. Tamblyn (Eds.), Health Technology Assessment Policy and Methods Review: HTA Pathways and Processes, Clinical Evaluation Methods and Horizon Scanning (pp. 347-492). Canberra, ACT: Commonwealth of Australia. 2024 Tamblyn, D., Morona, J., Carter, D., Kessels, S., & Merlin, T. (2024). Clinical Evaluation Methods in HTA. In T. Merlin, & D. Tamblyn (Eds.), Health Technology Assessment Policy and Methods Review: HTA Pathways and Processes, Clinical Evaluation Methods and Horizon Scanning (pp. 347-492). Canberra, ACT: Commonwealth of Australia. -
Conference Papers
Year Citation 2009 Beckmann, K., Pinnock, C. B., Tamblyn, D. J., Kopsaftis, T., Stapleton, A. M. F., & Roder, D. (2009). Prostate cancer in South Australia: equitable access but later presentation. In BJU INTERNATIONAL Vol. 103 (pp. 11-12). Gold Coast, AUSTRALIA: WILEY-BLACKWELL PUBLISHING, INC. -
Conference Items
Year Citation 2015 Vogan, A., Mitchell, A., Tamblyn, D., & Merlin, T. (2015). Managed Entry Schemes: Enabling Access To Oncology Drugs Under Uncertainty. Poster session presented at the meeting of the 12th Annual Health Technology Assessment international (HTAi) Conference. Oslo, Norway. 2013 Moshi, M. R., Tamblyn, D., & Merlin, T. (2013). Rise of Co-dependent Technologies: Surveying Stakeholders’ about their opinion on the co-dependent technology framework and decision-making process [Poster]. Poster session presented at the meeting of SA State Population Health Conference. Adelaide, South Australia. 2013 Merlin, T. L., Ellery, B., Juneja, V., & Tamblyn, D. (2013). What’s in a name? - Mapping the different HTA products of INAHTA members. Poster session presented at the meeting of the 10th Annual Meeting Health Technology Assessment international (HTAi). Seoul, South Korea. -
Report for External Bodies
Year Citation 2023 Laka, M., Carter, D., Gao, Y., Choi, O., Tamblyn, D., & Merlin, T. (2023). International health technology market approval, funding and assessment pathways. Canberra: Australian Department of Health and Aged Care. 2023 Tamblyn, D., Morona, J., Carter, D., Kessels, S., & Merlin, T. (2023). Clinical Evaluation Methods in HTA. Canberra: Australian Department of Health and Aged Care. 2022 Kessels, S., Mittal, R., Newton, S., & Tamblyn, D. (2022). Review of different minimally invasive therapeutic approaches for the management of patients with benign prostatic hyperplasia (MSAC FFP review 1697). Canberra: Commonwealth of Australia. 2022 Milverton, J., Demir, M., Carter, D., Hill, H., Parsons, J., Tamblyn, D., & Vogan, A. (2022). Genetic testing for children with hearing impairment (MSAC Application 1680). Canberra: Commonwealth of Australia. 2020 Tamblyn, D., Vogan, A., Parsons, J., Schubert, C., Bellman, S., & Carter, D. (2020). Technical report to supplement clinical utility card for genetic testing for diagnosis of inheritable cardiomyopathies (MSAC Application 1599). Canberra: Commonwealth of Australia. 2020 Tamblyn, D., Vogan, A., Parsons, J., Schubert, C., Bellman, S., & Carter, D. (2020). Clinical utility card for heritable cardiomyopathies. 2016 Tamblyn, D., Schubert, C., & Merlin, T. L. (2016). Guidelines for preparing a submission to the Pharmaceutical Benefits Advisory Committee, Version 5.0. Commonwealth of Australia. 2012 Morona, J. K., Newton, S., Wang, S., Tamblyn, D., Ellery, B., & Merlin, T. (2012). Genetic testing for hereditary mutations in the VHL gene that cause von Hippel-Lindau syndrome (MSAC Application number 1153,). Canberra, ACT.: Commonwealth of Australia. -
NHMRC Endorsed Guidelines
Year Citation 2015 Title: National Evidence-Based Guideline on Secondary Prevention of Cardiovascular Disease in Type 2 Diabetes
Authors: Morona J, Tamblyn D, Ellery B, Merlin T
Author affiliation: A1007279-A1050252-A1068278-A1018746
Publisher: Commonwealth of Australia - Department of Health
Place of publication: Australia
Publication date: 2015
ISBN-13: 9780980604092
Source URL: http://t2dgr.bakeridi.edu.au/LinkClick.aspx?fileticket=H_EpLXHAX_s=&tabid=172
Verification-status: Verified
Record created at source: 15 April 20162011 Publication status: Published
Title: National evidence-based guideline: Prevention, identification and mangement of foot complications in diabetes
Authors: Fitridge R, Templeton S, Buckley E, Docter S, Morona J, Reddin E, Juneja V, Merlin T
Author affiliation: A1066006-A1066294-B1134193-B1181052-B1007279-B1200662-B1216790-B1050252-B1183605-B1068278-B1177181-B1018746
Pagination: 0 pages
Publication date: 2011
Language: en
Notes: Migrated record 20140814
Verification-status: Verified
Record created at source: 14 August 2014
Mr Tamblyn has taught into the University of Adelaide bachelor of medicine and surgery, and into both undergraduate and post-graduate public health. Topics covered include health economics, evaluation methods and epidemiology.
-
Consulting/Advisories
Date Institution Department Organisation Type Country 2021 - ongoing South Australian Medicines Evaluation Panel (SAMEP) SA Health Health services and related Australia 2018 - 2023 National Health and Medical Research Council National Health and Medical Research Council Health services and related Australia 2018 - ongoing South Australian Policy Advisory Committee on Technology (SAPACT) SA Health Health services and related Australia 2018 - ongoing TGA Expert Advisory Panel, Breast Implant Associated ALCL Therapeutics Goods Administration Health services and related Australia 2017 - ongoing International Journal for Technology Assessment in Health Care Editors Scientific research United Kingdom -
Presentation
Date Topic Presented at Institution Country 2017 - 2017 Pharmaceutical Benefits Advisory Committee (PBAC) Guidelines Evaluator Workshop Canberra AHTA, presenting at request of Australian Government Department of Health Australia 2016 - 2016 Pharmaceutical Benefits Advisory Committee (PBAC) Guidelines Review Submission Sponsor Workshop Sydney (3), Melbourne (2) AHTA, presenting at request of Australian Government Department of Health Australia
Connect With Me
External Profiles
